Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases

Giuseppe Legname, Tommaso Virgilio, Edoardo Bistaffa, Chiara Maria Giulia De Luca, Marcella Catania, Paola Zago, Elisa Isopi, Ilaria Campagnani, Fabrizio Tagliavini, Giorgio Giaccone, Fabio Moda

Research output: Contribution to journalArticle

Abstract

Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/−) or knock-out (Pin1−/−) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.

Original languageEnglish
Pages (from-to)127-137
Number of pages11
JournalPrion
Volume12
Issue number2
DOIs
Publication statusPublished - Mar 4 2018

Fingerprint

Peptidylprolyl Isomerase
Prion Diseases
Protein Stability
Prions
Huntington Disease
Neurodegenerative Diseases
Parkinson Disease
Alzheimer Disease
Animals
Down-Regulation
Animal Models
Peptides
Proteins

Keywords

  • neurodegeneration
  • Pin1
  • PMCA
  • prion

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Infectious Diseases

Cite this

Legname, G., Virgilio, T., Bistaffa, E., De Luca, C. M. G., Catania, M., Zago, P., ... Moda, F. (2018). Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases. Prion, 12(2), 127-137. https://doi.org/10.1080/19336896.2018.1464367

Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases. / Legname, Giuseppe; Virgilio, Tommaso; Bistaffa, Edoardo; De Luca, Chiara Maria Giulia; Catania, Marcella; Zago, Paola; Isopi, Elisa; Campagnani, Ilaria; Tagliavini, Fabrizio; Giaccone, Giorgio; Moda, Fabio.

In: Prion, Vol. 12, No. 2, 04.03.2018, p. 127-137.

Research output: Contribution to journalArticle

Legname, G, Virgilio, T, Bistaffa, E, De Luca, CMG, Catania, M, Zago, P, Isopi, E, Campagnani, I, Tagliavini, F, Giaccone, G & Moda, F 2018, 'Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases', Prion, vol. 12, no. 2, pp. 127-137. https://doi.org/10.1080/19336896.2018.1464367
Legname G, Virgilio T, Bistaffa E, De Luca CMG, Catania M, Zago P et al. Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases. Prion. 2018 Mar 4;12(2):127-137. https://doi.org/10.1080/19336896.2018.1464367
Legname, Giuseppe ; Virgilio, Tommaso ; Bistaffa, Edoardo ; De Luca, Chiara Maria Giulia ; Catania, Marcella ; Zago, Paola ; Isopi, Elisa ; Campagnani, Ilaria ; Tagliavini, Fabrizio ; Giaccone, Giorgio ; Moda, Fabio. / Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases. In: Prion. 2018 ; Vol. 12, No. 2. pp. 127-137.
@article{c7a47f5e45904b5d96f80829b2b3df8c,
title = "Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases",
abstract = "Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/−) or knock-out (Pin1−/−) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.",
keywords = "neurodegeneration, Pin1, PMCA, prion",
author = "Giuseppe Legname and Tommaso Virgilio and Edoardo Bistaffa and {De Luca}, {Chiara Maria Giulia} and Marcella Catania and Paola Zago and Elisa Isopi and Ilaria Campagnani and Fabrizio Tagliavini and Giorgio Giaccone and Fabio Moda",
year = "2018",
month = "3",
day = "4",
doi = "10.1080/19336896.2018.1464367",
language = "English",
volume = "12",
pages = "127--137",
journal = "Prion",
issn = "1933-6896",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases

AU - Legname, Giuseppe

AU - Virgilio, Tommaso

AU - Bistaffa, Edoardo

AU - De Luca, Chiara Maria Giulia

AU - Catania, Marcella

AU - Zago, Paola

AU - Isopi, Elisa

AU - Campagnani, Ilaria

AU - Tagliavini, Fabrizio

AU - Giaccone, Giorgio

AU - Moda, Fabio

PY - 2018/3/4

Y1 - 2018/3/4

N2 - Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/−) or knock-out (Pin1−/−) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.

AB - Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/−) or knock-out (Pin1−/−) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.

KW - neurodegeneration

KW - Pin1

KW - PMCA

KW - prion

UR - http://www.scopus.com/inward/record.url?scp=85047105052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047105052&partnerID=8YFLogxK

U2 - 10.1080/19336896.2018.1464367

DO - 10.1080/19336896.2018.1464367

M3 - Article

C2 - 29676205

AN - SCOPUS:85047105052

VL - 12

SP - 127

EP - 137

JO - Prion

JF - Prion

SN - 1933-6896

IS - 2

ER -